Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-04-23 00:00:00 ET · period of report 2024-04-18 · accession 0001628280-24-017498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-23 | 2024-04-18 | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $15.31 | -481 | 158.7K | -0.3% | -$7,364 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-18 | S | D | 481 | $15.31 | 158,664 | D | — | — |